Amarantus Bioscience Holdings Inc (AMBS)

[Toolman1890]

Listen, he never said that. This is what he said:

"Author’s reply » Yes, they will definitely have to reverse split. However, market research shows that if you do a reverse split to maintain listing, you lose around 10-15% in value. If you do a reverse split to uplist (meaning move from the OTC to NASDAQ), you actually see an increase in value of 20-25%. Look at ONVO or TNXP as examples. Both stocks more than doubled in value after they uplisted.

At the current price, 20:1 gets you to around $2.25 per share.
I'd recommend they go bigger, more like 40:1 or 50:1. That would get the stock to $5.00 per share. This is the level where brokerage firms can start pitching the stock to non-accredited retail investors. $5.00 is a major inflection point for small-biotechs.

Of course, these are just my thoughts and the company will have to outline a path to uplisting when they are ready. Today's news is a positive step in that direction.

Jason

Please don't put words in others mouths'. Especially when anyone can go and verify what he said.